Teva Pharmaceuticals
TEVA
TEVA
727 hedge funds and large institutions have $18.5B invested in Teva Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 115 funds opening new positions, 204 increasing their positions, 318 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
3% more funds holding
Funds holding: 705 → 727 (+22)
1.99% more ownership
Funds ownership: 46.16% → 48.15% (+2%)
36% less repeat investments, than reductions
Existing positions increased: 204 | Existing positions reduced: 318
Holders
727
Holding in Top 10
32
Calls
$772M
Puts
$579M
Top Buyers
| 1 | +$877M | |
| 2 | +$379M | |
| 3 | +$229M | |
| 4 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$216M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$207M |
Top Sellers
| 1 | -$549M | |
| 2 | -$426M | |
| 3 | -$166M | |
| 4 |
SCM
Scopia Capital Management
New York
|
-$145M |
| 5 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
-$136M |